CNA Financial Near 52-Week High: Time to Buy, Sell or Hold the Stock?

CNA Financial (CNA) is trading near its 52-week high with a forward price-to-book value of 1.24X, below industry averages, and analysts project a 5.4% revenue increase for 2025 and a 10.8% EPS increase for 2026. The company's strong capital position supports a 3.6% dividend yield and a 10-year CAGR of 6.3%; however, CNA's exposure to catastrophe losses and rising expenses present ongoing concerns, leading to a Zacks Rank #3 (Hold) rating.

Analysis

CNA Financial Corporation (CNA) is trading near its 52-week high of $52.36, closing at $47.00, which suggests investor confidence despite its shares gaining only 5.5% in the past year, underperforming the P&C insurance industry's 22.7% growth and the Finance sector's 17.4% rise. The company presents an attractive valuation with a forward price-to-book value of 1.24X, below the industry average of 1.54X and supported by a Value Score of B. Revenue growth is projected at 5.4% for 2025 to $13.43 billion, with consensus estimates for 2026 indicating a 10.8% increase in EPS and a 3.5% rise in revenue from 2024 levels. However, analyst sentiment is mixed: while 2026 earnings estimates have risen 1.3% in the past 30 days, 2025 earnings estimates have declined 5.4% over the same period. Positively, CNA's premium growth is expected to continue, driven by solid retention and new business across its segments, and its fixed-income investment strategy is well-positioned. The company maintains a robust balance sheet, with $11 billion in statutory capital and surplus in Q1, and offers a compelling 3.6% dividend yield, reflecting a 10-year CAGR of 6.3% and a commitment to shareholder returns. CNA's trailing 12-month ROE of 11.9% also surpasses the industry average of 7.8%. Key concerns include inherent exposure to catastrophe losses, such as those from Hurricane Milton, and escalating expenses, which could impact profitability, leading to a Zacks Rank #3 (Hold) status.

Key Decisions for Investors

• Investors should weigh CNA's attractive valuation (P/B 1.24X) and strong dividend yield (3.6%) against its recent share price underperformance and the mixed analyst outlook, particularly the downward revision in 2025 earnings estimates.
• Monitor the impact of catastrophe losses on underwriting results and the company's ability to manage escalating operating expenses, as these are key risks to profitability.
• Given the Zacks Rank #3 (Hold) and the article's suggestion to wait, consider maintaining current positions or delaying new investments until there is greater clarity on earnings trajectory and mitigation of expense pressures, despite positive long-term fundamentals like premium growth and capital strength.